HCPCS Codes for Medical care


  • J0693

    Injection, cefiderocol, 5 mg
  • J0694

    Injection, cefoxitin sodium, 1 gm
  • J0695

    Injection, ceftolozane 50 mg and tazobactam 25 mg
  • J0696

    Injection, ceftriaxone sodium, per 250 mg
  • J0697

    Injection, sterile cefuroxime sodium, per 750 mg
  • J0698

    Injection, cefotaxime sodium, per gm
  • J0699

    Injection, cefiderocol, 10 mg
  • J0701

    Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
  • J0702

    Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
  • J0703

    Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
  • J0706

    Injection, caffeine citrate, 5 mg
  • J0710

    Injection, cephapirin sodium, up to 1 gm
  • J0712

    Injection, ceftaroline fosamil, 10 mg
  • J0713

    Injection, ceftazidime, per 500 mg
  • J0714

    Injection, ceftazidime and avibactam, 0.5 g/0.125 g
  • J0715

    Injection, ceftizoxime sodium, per 500 mg
  • J0716

    Injection, centruroides immune f(ab)2, up to 120 milligrams
  • J0717

    Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J0720

    Injection, chloramphenicol sodium succinate, up to 1 gm
  • J0725

    Injection, chorionic gonadotropin, per 1,000 usp units
  • J0735

    Injection, clonidine hydrochloride, 1 mg
  • J0736

    Injection, clindamycin phosphate, 300 mg
  • J0737

    Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
  • J0738

    Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
  • J0739

    Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
  • J0740

    Injection, cidofovir, 375 mg
  • J0741

    Injection, cabotegravir and rilpivirine, 2mg/3mg
  • J0742

    Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
  • J0743

    Injection, cilastatin sodium; imipenem, per 250 mg
  • J0744

    Injection, ciprofloxacin for intravenous infusion, 200 mg
  • J0745

    Injection, codeine phosphate, per 30 mg
  • J0750

    Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
  • J0751

    Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
  • J0752

    Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
  • J0759

    Injection, clevidipine butyrate, 1 mg
  • J0760

    Injection, colchicine, per 1 mg
  • J0770

    Injection, colistimethate sodium, up to 150 mg
  • J0775

    Injection, collagenase, clostridium histolyticum, 0.01 mg
  • J0780

    Injection, prochlorperazine, up to 10 mg
  • J0791

    Injection, crizanlizumab-tmca, 5 mg
  • J0795

    Injection, corticorelin ovine triflutate, 1 microgram
  • J0799

    Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
  • J0800

    Injection, corticotropin, up to 40 units
  • J0801

    Injection, corticotropin (acthar gel), up to 40 units
  • J0802

    Injection, corticotropin (ani), up to 40 units
  • J0833

    Injection, cosyntropin, not otherwise specified, 0.25 mg
  • J0834

    Injection, cosyntropin, 0.25 mg
  • J0840

    Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
  • J0841

    Injection, crotalidae immune f(ab')2 (equine), 120 mg
  • J0850

    Injection, cytomegalovirus immune globulin intravenous (human), per vial